ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Climb Bio Inc

Climb Bio Inc (CLYM)

1.98
0.06
(3.13%)
Closed December 24 3:00PM
1.98
0.00
(0.00%)
After Hours: 4:00PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
1.98
Bid
1.96
Ask
2.22
Volume
402,535
1.87 Day's Range 2.06
1.86 52 Week Range 5.86
Previous Close
1.92
Open
1.91
Last Trade
10
@
2.08
Last Trade Time
Average Volume (3m)
322,533
Financial Volume
US$ 799,989
VWAP
1.9874

CLYM Latest News

Climb Bio to be Added to the Nasdaq Biotechnology Index

WELLESLEY HILLS, Mass., Dec. 19, 2024 (GLOBE NEWSWIRE) -- December 19, 2024 – Climb Bio, Inc. (Nasdaq: CLYM) today announced that the company will be added to the NASDAQ Biotech Index (Nasdaq:...

Climb Bio Reports Third Quarter 2024 Financial Results and Business Highlights

Appointed Douglas Williams, Ph.D. as Chair of the Board of Directors FDA Clearance of Investigational New Drug Application (IND) for systemic lupus erythematosus (SLE) Expanded Management Team...

Climb Bio Appoints Douglas E. Williams, Ph.D., as Chair of the Board

WELLESLEY, Mass., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM) today announced the appointment of Douglas E. Williams, Ph.D., as Climb Bio’s Chair of its Board of Directors...

Climb Bio to Present at Upcoming Investor Conferences

WELLESLEY, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), announced that members of its executive team are scheduled to participate in the upcoming investor conferences...

Climb Bio to Provide Budoprutug Development Strategy and Corporate Update at Virtual Investor Event

Completes Transition to Immune-Mediated Disease Focused Company Highlights Additional Data from Phase 1b Primary Membranous Nephropathy (pMN) Study with plans to Advance to Late Phase Development...

Climb Bio Announces Abstract Selected for Presentation at the American Society of Nephrology Kidney Week 2024

WELLESLEY, Mass., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), announced that it will present data at the American Society of Nephrology Kidney Week 2024, which will take...

Climb Bio to Present at William Blair’s Upcoming Conference Event on Transforming Autoimmune Diseases by Targeting CD19

WELLESLEY, Mass., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), announced today it will present and host investor meetings at William Blair’s Transforming Autoimmune Diseases...

Climb Bio to Host Virtual Investor Event on October 15, 2024

WELLESLEY, Mass., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), announced today it will host a virtual investor day on October 15, 2024. The event will feature members of...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.39-16.45569620252.372.481.866405461.97432147CS
4-1.13-36.33440514473.113.31.862697002.35174866CS
12-3.05-60.63618290265.035.861.863225333.64008359CS
26-3.05-60.63618290265.035.861.863225333.64008359CS
52-3.05-60.63618290265.035.861.863225333.64008359CS
156-3.05-60.63618290265.035.861.863225333.64008359CS
260-3.05-60.63618290265.035.861.863225333.64008359CS

CLYM - Frequently Asked Questions (FAQ)

What is the current Climb Bio share price?
The current share price of Climb Bio is US$ 1.98
What is the 1 year trading range for Climb Bio share price?
Climb Bio has traded in the range of US$ 1.86 to US$ 5.86 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BAOSBaosheng Media Group Holdings Ltd
US$ 7.10
(310.40%)
58.74M
HOURHour Loop Inc
US$ 4.40
(207.69%)
97.42M
GTIGraphjet Technology
US$ 0.61
(168.72%)
265.48M
CREVCarbon Revolution Public Ltd
US$ 9.16
(135.48%)
26.95M
AVGRAvinger Inc
US$ 1.45
(125.72%)
107.53M
SLGLSol Gel Technologies Ltd
US$ 0.9798
(-40.62%)
3.07M
DRCTDirect Digital Holdings Inc
US$ 3.71
(-32.55%)
23.82M
CHEKCheck Cap Ltd
US$ 1.55
(-31.11%)
3.49M
SYTASiyata Mobile Inc
US$ 0.5178
(-30.83%)
2.63M
BTFValkyrie ETF Trust II CoinShares Bitcoin and Ether Stratagy ETF
US$ 15.47
(-30.38%)
147.98k
SVMHSRIVARU Holding Ltd
US$ 0.0338
(20.71%)
280.27M
GTIGraphjet Technology
US$ 0.61
(168.72%)
265.48M
LITMSnow Lake Resources Ltd
US$ 0.5849
(52.84%)
181.22M
LCIDLucid Group Inc
US$ 3.20
(3.23%)
108.75M
RGTIRigetti Computing Inc
US$ 11.35
(3.56%)
108.38M

Discussion

View Full Feed
StayHumble StayHumble 4 minutes ago
wow💹15 BILLION+ Historic BUYS💹Lots of Xperts Here💹 https://ih.advfn.com/stock-market/USOTC/humbl-pk-HMBL/historical
HMBL
Nelson2 Nelson2 5 minutes ago
Hit .25 cents today!!

GLTA
VSQTF
Top Penny Top Penny 5 minutes ago
Merry Christmas! Now let's buy buy buy!
MONI
StockItOut StockItOut 6 minutes ago
A present for all

https://www.courtlistener.com/audio/94659/xeriant-inc-v-auctus-fund-llc/
XERI
Cflores32097 Cflores32097 7 minutes ago
Ahh well Santa Frank will dump more!
IDGR
OMOLIVES OMOLIVES 7 minutes ago
Merry Christmas....Hanukkah...Dong Zhi....Yalda...or just good ole' paganism......what ever you celebrate. Have a blessed time with family and freinds or just yourself...love yall' n' all...

Be Free......

:)
Acme Investments Acme Investments 7 minutes ago
Miracle on 34th Street!!
BCAP
Cflores32097 Cflores32097 8 minutes ago
Greg Evan’s cbd Christmas honey?
IDGR
BreakingNews1 BreakingNews1 8 minutes ago
$RDAR Is The Investment Community’s Consensus Top Pick For 2025 with $300 Million in Revenues and a $45 million working capital facility to drive accelerated growth.

https://telvantis.com/press-releases/
RDAR
StockItOut StockItOut 9 minutes ago
Merry Christmas, man, but really, get a doctor.
XERI
Cflores32097 Cflores32097 12 minutes ago
Again tell me why franks in Philippines??
IDGR
madcasper madcasper 13 minutes ago
thanks for the update
BMNR
BMNR
Cflores32097 Cflores32097 13 minutes ago
Frank and Charles back to dump fest
IDGR
Cflores32097 Cflores32097 14 minutes ago
They out crooked David 🤣 he’s gone
IDGR
Cflores32097 Cflores32097 14 minutes ago
Jzzi repeat lmao 🚮
IDGR
Cflores32097 Cflores32097 14 minutes ago
Notice they won’t update the float again
IDGR
HappyAlways HappyAlways 14 minutes ago
Merry Christmas to all. Our time has started at $0.3 not too long ago and will keep coming. My timeline is 2 months after DJT in office, we will see another WH Memo to release the GSEs. 2025 will be a big booom to the GSEs shareholders. 
DJT
Risk vs Reward Risk vs Reward 15 minutes ago
Hedge Funds can't but until a close of 5.00

What the F are you taking about " institutions " 


KULR
Hosai Hosai 20 minutes ago
Not quite clear how influential he is but nice to see the 'head of tax North America' at Sanofi gave a clapping emoji for the EMA accepted PR. - https://www.linkedin.com/in/robert-ridolfi-b338977/

Though acually looking further at his history he likes every Anavex post.
AVXL
krab krab 22 minutes ago
I believe it should reach greener pastures of $4+ in late Jan 2025.
Until then lots of consolidating and scare tactics, fake reports to capture shares from the weaker hands.
Merry Xmas, Prosperous & Happy New Year to everyone holding FnF.
Enjoy your precious time your family &
FNMA
misterfishman misterfishman 22 minutes ago
I would rather see a massive stock retire or buyback.
IGPK
GoodGuyBill GoodGuyBill 23 minutes ago
Of course you don't see NWBO involved in anything positive. What else is new?
NWBO

Your Recent History

Delayed Upgrade Clock